AGP Picks
View all

AGP Executive Report

Your go-to archive of top headlines, summarized for quick and easy reading.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

Staffing Crisis: Sri Lanka says government hospitals are short about 7,000 medical officers, with phased recruitment planned for 2027–29. Youth Gender Care: Australia’s medical research council says puberty blockers may be considered for some young people under clinical guidance, but Queensland and the Northern Territory will not prescribe them in public hospitals. Drug Safety: Breckenridge recalled one lot of 60 mg extended-release propranolol over possible metal fragments that could cause internal cuts; patients should check lot PK25110035 and contact a pharmacist promptly before changing treatment. Weight-Loss Access: A study found Medicaid prescriptions for GLP-1 weight-loss drugs fell about 84% in four states after coverage ended, leaving many patients to pay out of pocket or stop treatment. Cancer Research: CG Oncology says its experimental bladder cancer drug cut recurrence risk by 68% versus surveillance in a Phase 3 trial. New Medicines: Sanofi struck a deal worth up to $1.2 billion with US biotech Seawolf to develop DNA-based medicines, including treatments for bleeding disorders.

Flu Protection: A review of 18 seasons found vaccine effectiveness against medically attended flu had a median of 39.5%, but varied widely—challenging the familiar 40%–60% message. Antibiotic Resistance: Australia’s medical association says reports of critical resistance rose 25% in 2024, warning that routine procedures could become riskier without stronger action. Alzheimer’s Risk: Mayo Clinic researchers say a blood test combined with age, sex and genetic risk may help estimate a healthy person’s chance of cognitive impairment over the next five or 10 years. Medicine Access: Medicaid prescriptions for weight-loss GLP-1 drugs fell about 84% in four states after coverage ended, a study found. Safety Rules: Updated FDA requirements allow some isotretinoin pregnancy tests to be done at home after treatment begins, while keeping safeguards against fetal exposure. Women’s Health: Reports from Afghanistan say restrictions and a shortage of female doctors are obstructing women’s access to examinations and emergency care.

Antimicrobial Resistance: The WHO warns drug resistance threatens routine surgery, childbirth and cancer care. More than 1 million people died directly from antimicrobial resistance in 2021; current trends could lead to 39 million deaths over the next 25 years. Young-Onset Diabetes: A PGIMER study found 33% of patients diagnosed with type 2 diabetes before age 25 developed complications within five years, compared with 8% of those with type 1. Researchers say care should address heart and blood-vessel risks as well as blood sugar. Children’s Heart Care: A Chinese medical team performed open-heart surgery on a 15-month-old Nigerian child with a congenital defect, working alongside local staff after the child had been unable to access the operation locally. Drug Safety: Punjab ordered five injectable medicines recalled after tests found quality problems, including visible particles and failed sterility checks. Heart Treatment: The FDA updated the prescribing information for aficamten to include trial data comparing it with metoprolol in adults with obstructive hypertrophic cardiomyopathy; the company says the drug improved exercise capacity and symptoms.

Community Care: A Chinese medical team offered free consultations, diabetes screening and basic medicines on Tanzania’s Pemba Island, where residents often travel long distances for care. GLP-1 Drugs: The medicines may benefit heart, kidney and brain health, but a CVS analysis found their current prices outweighed medical savings for insurers; researchers estimated costs would need to fall to about $350 a month to balance out. Medicine Access: ASEAN leaders urged countries to diversify medicine suppliers, share purchasing power and expand regional manufacturing amid global uncertainty. Coverage Changes: US states can delay enforcing Medicaid work requirements for up to six months, giving them more time to prepare systems that could affect patients’ access to care. Drug Safety: South Australian authorities investigated three medication errors at a youth detention centre since early 2025; none caused harm, but concerns remain about gaps in round-the-clock health services. China’s Drug Coverage: Procurement of medicines added to China’s insurance catalog through negotiations rose 48% in 2025, and an expanded list of 3,331 drugs is due to take effect in 2027.

Medicine Supply: At the ASEAN summit, Malaysia’s prime minister urged members to diversify medicine sources, recognize one another’s regulatory approvals and strengthen regional production to reduce reliance on outside suppliers. Drug Safety: A review found Jersey’s medicines and medical-device oversight has gaps in safety monitoring, legal safeguards and accountability, raising public-health risks; an overhaul is under way, with no completion date set. Drug Recall: Nearly 24,000 bottles of amiodarone, used for serious heart-rhythm disorders, are being recalled in the U.S. after a foreign substance was found. The FDA has not identified the substance. Health Coverage: U.S. states may delay Medicaid work-rule cutoffs until July 2027, but reporting requirements begin Jan. 1 and states must opt in to the delay. Health Workforce: WHO and Bahrain’s RCSI Medical University agreed to work together on health education, research and emergency preparedness. Pharma Investment: Eli Lilly is considering a $1 billion investment in Hyderabad, which already accounts for about 40% of India’s bulk-drug production. Conflict and Care: Iran’s government says U.S.-Israeli strikes damaged a major pharmaceutical company making cancer and anesthetic drugs.

Drug Access: China has added 107 medicines to its national insurance list, including 51 innovative drugs; coverage begins in January 2027. Medicaid: The U.S. will let states delay enforcing new work requirements until July 2027, giving them six more months before eligible adults could lose coverage for not meeting the rules. Cancer Research: In a Phase 3 trial, a personalized melanoma vaccine combined with Keytruda kept 82.2% of patients free of recurrence or death at two years, compared with 70% on Keytruda alone. The vaccine remains experimental. Medicine Supply: Russia still relies on imports, which accounted for 56% of medicine spending in the first eight months of 2026, despite efforts to build domestic production. Gaza: An Israeli strike on Nasser Hospital killed six people and injured 28, according to reports; 18 countries condemned the attack, which damaged key medical departments. Diabetes: A small study suggests an evening walk may help curb post-dinner blood sugar spikes, though walking at any time offers health benefits.

Hospital Safety: A strike on Gaza’s Nasser Medical Complex killed six people and injured more than 20, renewing concerns over attacks on healthcare facilities. Custody Care: ICE’s reviews found deficient medical care before 23 of 29 detainee deaths; investigators said it contributed to 20, and staff failed to perform CPR properly in at least eight cases. Medicaid: Federal officials gave states the option to delay enforcing new work requirements until July 2027, reducing the risk of people losing coverage because systems aren’t ready. Diabetes Care: Daily oral GLP-1 drugs could ease access in countries where costly injections and cold storage are harder to manage. The FDA has also required a warning about rare vision loss linked to the medicines. Medicine Access: Patients in Malawi still report leaving public hospitals without prescribed drugs amid funding and supply-chain problems. Drug Industry: Chinese pharmaceutical companies are exploring AI medical apps to reach doctors as an anti-graft crackdown curbs traditional sales visits.

Drug Safety: The FDA is requiring GLP-1 drug labels to warn of a rare vision-loss risk. Separately, 3,684 bottles of blood-pressure drug metoprolol were recalled nationwide after they may have contained foreign pills. Medicine Supply: Quva Pharma is transferring hospital-drug production from CAPS, which exited sterile compounding, and has hired 36 former CAPS staff as it works to restore supplies. Cancer Care: Portneuf Medical Center has introduced AI to flag suspicious lung nodules and robotic bronchoscopy to biopsy smaller, hard-to-reach growths. Gaza: An Israeli airstrike on Nasser Medical Complex killed six people, including a surgeon, and injured more than 20, Malaysia’s Foreign Ministry said. Community Health: A new 85-bed medical respite center in Mesa, Arizona, will provide round-the-clock care for people without housing after hospital discharge.

Hospital Safety: A Russian drone attack damaged a medical facility in Kyiv, injuring three patients and forcing others to move to different departments. Medicine Access: South Africa reports medicine availability of 83.4%, but patients and monitors describe shortages of essential drugs, including treatments for diabetes and psychiatric conditions. Drug Policy: The European Parliament’s health committee has backed a major medicines reform; a full Parliament vote remains before a two-year implementation period begins. Heart Failure Care: Ventric Health and Stellus Rx will link rapid, non-invasive heart-failure testing with pharmacist-led medication management in primary care. Medical Education: Malaysia will preserve direct-entry eligibility to private medical degrees for UEC holders who meet the existing minimum grades. Health Workforce: Sri Lanka’s medical alliance chief warns that limited support for doctors could fuel more departures overseas.

Drug-Resistant Infections: An inhaled, engineered bacterium thinned antibiotic-resistant lung biofilms by about 40% in pigs, a promising but early step toward treating infections linked to breathing tubes. Medicaid Coverage: Congressional Democrats are urging the administration to delay work-reporting rules due Jan. 1, warning states lack time to prepare and eligible people could lose coverage. Medicine Safety: Georgia officials warned consumers about online pharmacies selling counterfeit, expired or improperly stored drugs. Drug Access: New research found average state-level pharmacy benefit manager market concentration more than doubled over the past decade, alongside growth in prescription tiers that can raise patients’ costs and community pharmacy closures. Supply Shortages: A review of Australia’s medicine shortages flagged repeated critical shortages of Bicillin L-A and prolonged shortages of Creon, underscoring risks to patients who have few alternatives.

Diabetes Prevention: Ghana’s Komfo Anokye Teaching Hospital medical director urged families to choose nutritious local foods to help prevent diabetes. Trauma Care: Medica-Liberia launched a five-year program to train providers in trauma-sensitive care and improve support for survivors. Alzheimer’s Research: Roche will present new drug and blood-test data at a meeting later this month; its Phase III trial of an investigational treatment for preclinical Alzheimer’s has begun enrolling. Liver Disease: Early human results for Regeneron’s experimental RNA therapy showed reduced liver fat in adults with MASLD, a common chronic liver condition. Safer Medicines: WHO and the African Medicines Agency are expanding regulatory cooperation; 10 African national regulators have reached a level indicating established, integrated oversight systems. Local Health Capacity: Kyrgyzstan is building a $41.2 million pharmaceutical complex to make medicines, capsules and saline solutions, while Afghanistan’s health exhibition showcased domestic drug production. Hospital Services: A Philippine charity donated $17.8 million pesos in equipment and two patient transport vehicles to hospitals in Oriental Mindoro, including ventilators and an X-ray machine.

AI & Prescribing: A study in The Lancet Digital Health found drug ads could sway AI treatment advice: models chose the advertised drug in 47.6% of responses with an ad, versus 35% without one. Newborn Care: An international study spanning 30 neonatal intensive care units in 20 countries explored adapting adult AI radiograph models for newborns, while protecting patient data. Medication Choices: Research using nearly 100,000 health records found genetic differences can affect how people respond to medicines; the researchers say testing could improve treatment, though it is not yet routine. Drug Safety: Doctors are urging patients on GLP-1 medicines to report new vision problems, alongside persistent stomach symptoms or significant hair loss. Pharma Watch: The FDA had 1,343 fewer employees in its drug and biologics centers in September than two years earlier, raising concerns about staffing delays. Aspen Pharmacare also won approval to sell generic semaglutide in Brazil and South Africa.

Drug Access: Aspen Pharmacare won approval for generic injectable semaglutide in Brazil and South Africa, with launches expected in the coming months—potentially widening access to diabetes and weight-loss treatment. Medicine Safety: The FDA warned of a rare eye condition linked to some GLP-1 drugs. Separately, a doctor cautioned that chatbot advice can be dangerous after a woman with epilepsy reportedly reduced her medication on ChatGPT’s advice and died. Care Access: France plans to add 70 mobile clinics, aiming for more than 100 by 2027 to serve communities short of doctors. New Treatment: Early CAR-T results in stiff-person syndrome were striking: two trial participants regained everyday abilities, though the findings are preliminary. Drug Quality: Nigeria’s NAFDAC urged medicine sellers to watch for fake and unregistered drugs and buy only from authorised suppliers.

Drug Safety: The FDA is requiring GLP-1 drug labels to warn of a rare eye condition that can cause sudden, permanent vision loss. The agency says the risk needs further assessment; patients should discuss concerns with their clinician. Medicare: Sen. Tammy Baldwin introduced a bill to let adults 50 to 64 buy into Medicare, while a separate federal request seeks input on easing Medicare’s physician-supervision rule for nurse anesthetists. Neither proposal is final. Coverage Risks: Nebraska’s Medicaid work rules have already left a cancer patient without coverage, underscoring concerns as more states prepare to enforce the requirements. Health Data: Australia is moving to require AI companies to report security incidents after an OpenAI-linked Medicare data breach. Rural Care: Minnesota will hold a public hearing on Sanford Luverne Medical Center’s plan to end inpatient labor, delivery and newborn services in April 2027.

Drug Safety: One in five Americans say they’ve been deceived into buying counterfeit medicines, with unapproved weight-loss drugs such as retatrutide among the risks. Separately, Eugia recalled a lot of vancomycin nationwide after a glass particle was found in a vial. Access to Treatment: Thirty-five cancer patients in Kosovo have gone two months without Avastin, which can cost up to €1,000 if bought privately. In South Africa, a freeze on new medical cannabis approvals is raising fears that patients with epilepsy and other serious conditions will lose access. New Treatment: The UAE has become the first country to approve Ultomiris for adults with IgA nephropathy at risk of worsening kidney disease. Air Quality: Delhi doctors report a surge in respiratory illness after Diwali celebrations, as pollution levels soar. Medicine Costs: Malaysia’s health inflation rose to 3% in 2025, with medicine prices up 2.8%.

Drug Safety: The FDA is requiring vision-loss warnings on GLP-1 labels. Clinicians are also urged to review insulin and sulfonylurea doses when patients start these drugs, as improved blood sugar control can raise hypoglycemia risk. Rural Care: Federal officials allocated another $10 billion to rural health systems across all 50 states, even as major Medicaid cuts threaten access; awards vary widely by state. Coverage Debate: Bernie Sanders is urging incoming Democratic lawmakers to lower Medicare eligibility to 55 and add dental, vision and hearing benefits, though major legislative hurdles remain. Access to Care: A survey found 31% of U.S. adults delayed or avoided care because of stigma. Of those, 91% reported consequences, including some who later needed emergency care. Global Health: AWS pledged $100 million in AI and cloud resources over five years for organizations working to close healthcare access and research gaps.

Drug Safety: A U.S. medicines-safety group warns counterfeit drugs are spreading through online sellers, telehealth and wellness clinics. It says one in five Americans has been tricked into buying fake medication, which may contain the wrong ingredient or dose. Medicaid Access: A Nebraska cancer patient says he was told he lost Medicaid coverage under new work rules, forcing him to cancel a scan and delay an appointment. Cancer Costs: India’s revised prices for 1,364 anti-cancer formulations could save patients an estimated ₹3,540 crore a year, officials say. Medicine Supply: U.S. agencies warn hackers targeting refrigeration systems could disrupt storage of temperature-sensitive medicines. Drug Shortages: In the Maldives, patients increasingly rely on travelers to bring prescriptions from abroad as shortages leave essential medicines unavailable locally.

Hypertension: A trial in Jamaica and Colombia found single-pill combinations controlled blood pressure better than usual multi-pill treatment, while improving medication adherence. Liver Disease: Early results for Regeneron’s experimental CIDEB siRNA showed one dose cut liver fat by up to 80% in people with fatty liver disease, with benefits lasting 36 weeks; further studies are needed. Care Access: Remote Area Medical is seeking volunteers for a free Memphis clinic on Feb. 6–7, offering medical, dental and vision care with no ID required. Drug Costs: India’s revised anti-cancer medicine prices take effect Nov. 9, with projected annual savings of more than ₹3,500 crore. Health Equity: Pediatrician Nadine Burke Harris called for care that addresses childhood adversity and community conditions, describing social determinants of health as a defining public-health challenge.

Public Medicines: Karnataka has ordered government hospitals to stop sending patients to outside pharmacies for prescribed drugs, requiring essential medicines to be provided free on site and warning of penalties for violations. Drug Safety: Pakistan’s regulator flagged nine counterfeit, adulterated or unregistered products sold in Karachi, including eye medicines and children’s mouthwash. A Philippine FDA official also warned consumers that supplements are not medicines and cannot claim to cure disease without meeting drug standards. Cancer Costs: India’s price caps on 1,031 cancer-drug formulations take effect Nov. 9; the government estimates patients could save about ₹3,502 crore a year. Access to Care: A Chilean survey found 78% of women delayed needed care in the past year, most often because of cost, long waits or lack of time.

Medicine Access: Namibia’s president is investigating distribution failures behind persistent medicine shortages in state clinics, despite improved procurement, and says officials are under investigation. Heart Research: A trial presented at the American Heart Association’s 2026 meeting suggests intravenous antiplatelet treatment may improve heart function in patients with cardiogenic shock after a heart attack compared with crushed oral medication. Cancer Drug Costs: India’s price caps on 137 cancer medicines take effect Nov. 9; reported price cuts reach 96%, with estimated annual savings of ₹3,502 crore for patients. Ebola Outbreak: The WHO reports 10,668 confirmed Bundibugyo virus cases and 5,198 deaths in the Democratic Republic of the Congo, with transmission continuing across eight provinces.

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.